Clinical Trial Update: A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy [Phase 2]

View source ↗

Summary

Phase II, single-center study assessing immune maintenance therapy after neoadjuvant immunotherapy plus chemotherapy in locally advanced head and neck squamous …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Head and Neck Cancer | Phase 2 | Status: RECRUITING